Cargando…
Engineered models of the human heart: Directions and challenges
Human heart (patho)physiology is now widely studied using human pluripotent stem cells, but the immaturity of derivative cardiomyocytes has largely limited disease modeling to conditions associated with mutations in cardiac ion channel genes. Recent advances in tissue engineering and organoids have,...
Autores principales: | Stein, Jeroen M., Mummery, Christine L., Bellin, Milena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452488/ https://www.ncbi.nlm.nih.gov/pubmed/33338434 http://dx.doi.org/10.1016/j.stemcr.2020.11.013 |
Ejemplares similares
-
Inherited heart disease – what can we expect from the second decade of human iPS cell research?
por: Bellin, Milena, et al.
Publicado: (2016) -
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017) -
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016) -
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
por: Campostrini, Giulia, et al.
Publicado: (2021) -
Toward Human Models of Cardiorenal Syndrome in vitro
por: Gabbin, Beatrice, et al.
Publicado: (2022)